Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Addus HomeCare CorpADUS · Entity 4454 | Director | June 15, 2022 | June 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Addus HomeCare Corp
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,807 |
Reported balance
After 2022-06-15 transaction · row 1
1 source rowRow 1 · 2022-06-15 · Grant · Acquired 1,406 · Balance 23,807 F1: Restricted shares granted to non-employee directors that will vest in full on June 15, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted to non-employee directors that will vest in full on June 15, 2023.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AMSURG CORP
Report date December 01, 2016 · Filed December 01, 2016
Section 16 reporting ended · disclosed 2016-12-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-01 transaction · row 1
1 source rowRow 1 · 2016-12-01 · Disposition to issuer · Disposed 23,864 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). |
| Common stockSEC Table I · non-derivative | IndirectBy family trust | 0 |
Reported balance
After 2016-12-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2016-12-01 · Disposition to issuer · Disposed 9,698 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.
F2: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
Envision Healthcare Corp
Report date October 11, 2018 · Filed October 15, 2018
Section 16 reporting ended · disclosed 2018-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-11 transaction · row 1
1 source rowRow 1 · 2018-10-11 · Disposition to issuer · Disposed 31,005 · Balance 0 F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F2: Includes 7,141 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. |
| Common StockSEC Table I · non-derivative | IndirectBy family trust | 0 |
Reported balance
After 2018-10-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-10-11 · Disposition to issuer · Disposed 9,698 · Balance 0 F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes.
F2: Includes 7,141 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU.
MedEquities Realty Trust, Inc.
Report date May 17, 2019 · Filed May 17, 2019
Section 16 reporting ended · disclosed 2019-05-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-05-17 transaction · row 1
1 source rowRow 1 · 2019-05-17 · Disposition to issuer · Disposed 25,939 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 2, 2019, by and among the issuer, MedEquities OP GP, LLC, MedEquities Realty Operating Partnership, LP, Omega Healthcare Investors, Inc. ("Omega") and OHI Healthcare Properties Limited Partnership, upon the closing of the transactions contemplated by the Merger Agreement, each share of the issuer's common stock owned by the reporting person immediately prior to the effective time of the merger was converted into the right to receive 0.235 shares of Omega common stock and $2.00 in cash, without interest. The closing price of Omega's common stock on May 16, 2019 (the date immediately prior to the effective time of the merger) was $37.67 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 2, 2019, by and among the issuer, MedEquities OP GP, LLC, MedEquities Realty Operating Partnership, LP, Omega Healthcare Investors, Inc. ("Omega") and OHI Healthcare Properties Limited Partnership, upon the closing of the transactions contemplated by the Merger Agreement, each share of the issuer's common stock owned by the reporting person immediately prior to the effective time of the merger was converted into the right to receive 0.235 shares of Omega common stock and $2.00 in cash, without interest. The closing price of Omega's common stock on May 16, 2019 (the date immediately prior to the effective time of the merger) was $37.67 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 20:42 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-037910 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,807 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 15, 2023. Read SEC document |
| November 22, 2021 Filed Nov 30, 2021 22:06 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-067152 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,401 Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:39 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042042 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 16, 2022. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 22:08 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056128 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,297 F1 · shares: Restricted shares granted to non-employee directors that will vest in full on June 15, 2021. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 15:49 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-037000 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 F1 · shares: Restricted shares granted to non-employee directors that will vest on the first anniversary of the date of grant. Read SEC document |
| May 17, 2019 Filed May 17, 2019 17:15 UTC | MedEquities Realty Trust, Inc. MRT · Entity 157425 | Disposition to issuerCommon Stock | 25,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000925421-19-000223 · edgar.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 2, 2019, by and among the issuer, MedEquities OP GP, LLC, MedEquities Realty Operating Partnership, LP, Omega Healthcare Investors, Inc. ("Omega") and OHI Healthcare Properties Limited Partnership, upon the closing of the transactions contemplated by the Merger Agreement, each share of the issuer's common stock owned by the reporting person immediately prior to the effective time of the merger was converted into the right to receive 0.235 shares of Omega common stock and $2.00 in cash, without interest. The closing price of Omega's common stock on May 16, 2019 (the date immediately prior to the effective time of the merger) was $37.67 per share. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 12:50 UTC | Envision Healthcare Corp EVHC · Entity 162981 | Disposition to issuerCommon Stock | 9,698 | $46.00 | $446,108.00 |
DisclosureSEC source: 0001678531-18-000146 · wf-form4_153962224228468.xml · nonDerivative · entry 2 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 0 F1 · shares: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F1 · price: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 12:50 UTC | Envision Healthcare Corp EVHC · Entity 162981 | Disposition to issuerCommon Stock | 31,005 | $46.00 | $1,426,230.00 |
DisclosureSEC source: 0001678531-18-000146 · wf-form4_153962224228468.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F2 · shares: Includes 7,141 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. F1 · price: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 22:06 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-037833 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,151 F1 · shares: Restricted shares granted to non-employee directors that will vest on the first anniversary of the date of grant. Read SEC document |
| May 25, 2018 Filed May 29, 2018 18:15 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 4,017 | $43.57 | $175,020.69 |
DisclosureSEC source: 0001678531-18-000080 · wf-form4_152763209757575.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,005 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 17:16 UTC | MedEquities Realty Trust, Inc. MRT · Entity 157425 | GrantCommon Stock | 6,684 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-18-000026 · edgar.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,939 F1 · shares: Represents a grant of restricted shares of common stock under the MedEquities Realty Trust, Inc. Amended and Restated 2014 Equity Incentive Plan, which shares will vest ratably on each of the first three anniversaries of the date of the grant, subject to the director's continued service on such dates. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 21:26 UTC | Addus HomeCare Corp ADUS · Entity 4454 | GrantCommon Stock | 2,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040600 · doc4.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,811 F1 · shares: Restricted shares granted to non-employee directors that will vest on the first anniversary of the date of grant. Read SEC document |
| May 25, 2017 Filed May 30, 2017 19:38 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 3,124 | $56.03 | $175,037.72 |
DisclosureSEC source: 0001678531-17-000131 · wf-form4_149618747511741.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,988 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 18:18 UTC | MedEquities Realty Trust, Inc. MRT · Entity 157425 | GrantCommon Stock | 6,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-17-000034 · edgar.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,255 F1 · shares: Represents a grant of restricted shares of common stock under the MedEquities Realty Trust, Inc. Amended and Restated 2014 Equity Incentive Plan, which shares will vest ratably on each of the first three anniversaries of the date of the grant, subject to the director's continued service on such dates. Read SEC document |
| December 01, 2016 Filed Dec 1, 2016 16:35 UTC | AMSURG CORP AMSG · Entity 180763 | Disposition to issuerCommon stock | 9,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000895930-16-000287 · wf-form4_148062808997317.xml · nonDerivative · entry 2 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 0 F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). Read SEC document |
| December 01, 2016 Filed Dec 1, 2016 16:35 UTC | AMSURG CORP AMSG · Entity 180763 | Disposition to issuerCommon stock | 23,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000895930-16-000287 · wf-form4_148062808997317.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 16:58 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 9,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-16-000067 · wf-form4_148071591197666.xml · nonDerivative · entry 2 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 9,698 F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of AmSurg Corp. common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by the Company and converted into one share of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to AmSurg Corp. plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that AmSurg Corp.'s outstanding performance awards issued pursuant to the Performance Share Unit Award Agreement (the "Agreement") under its 2014 Equity and Incentive Plan (the "Plan") that were eligible to vest settled into shares of restricted stock at the Target Award (as defined in the Agreement) upon consummation of the Mergers, as the Mergers constituted a Change of Control (as defined in the Plan). Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 16:58 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 23,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-16-000067 · wf-form4_148071591197666.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,864 F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of AmSurg Corp. common stock held by the reporting person immediately prior to the Merger 1 Effective Time was assumed by the Company and converted into one share of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to AmSurg Corp. plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that AmSurg Corp.'s outstanding performance awards issued pursuant to the Performance Share Unit Award Agreement (the "Agreement") under its 2014 Equity and Incentive Plan (the "Plan") that were eligible to vest settled into shares of restricted stock at the Target Award (as defined in the Agreement) upon consummation of the Mergers, as the Mergers constituted a Change of Control (as defined in the Plan). Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 16:35 UTC | MedEquities Realty Trust, Inc. MRT · Entity 157425 | PurchaseCommon Stock | 5,000 | $12.00 | $60,000.00 |
DisclosureSEC source: 0000925421-16-000183 · edgar.xml · nonDerivative · entry 1 GERINGER STEVEN I · CIK 0001203383 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,499 F1 · price: These shares were purchased from the underwriters in the initial public offering that closed on October 4, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.